Sickle Cell Scholar component

镰状细胞学者组件

基本信息

  • 批准号:
    7821230
  • 负责人:
  • 金额:
    $ 30.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

The Sickle Cell Scholar Program offers a method of recruiting and training young investigators in the field of sickle cell disease. The scholar project can be a basic science, translational, clinical or patient services outcome project. The scholar must be two years post MD or PhD and must have some research experience by the time of the award. The scholar will not be recruited until after the awards are determined by the NHLBI, and the project will be determined at that time. The purpose of the Sickle Cell Scholar Plan is to describe the method of recruiting the scholar, to provide a mentorship plan for the scholar and to describe the facilities available to support mentorship. St. Jude Children's Research Hospital (SJCRH) has sponsored two Sickle Cell Scholars in the last CSCC 5 year cycle and plans to sponsor two researchers for this cycle. The current scholar, Dr. Claudia Hillebrand, is mentored by the Central Nervous System Core Director, Dr. Kathleen Helton. Dr. Hillebrand was instrumental in several local protocols including the study led by Dr. Hankins, Clinical Core Director: Pilot Study of Non-lnvasice Assessment of Hepatic and Myocardial Iron Through MRI T2* in Patients with Transfusional Iron Overload (MRIRON). Dr. Hillenbrand helped developed the software for the current local study (MRIRON) to find a non-invasive alternative to assess iron overload in patients with sickle cell disease through the use of MRI techniques. Currently, SJCRH has more than 270 postdoctoral fellows in residence at the hospital and has outstanding support programs for these fellows including a Postdoctoral Fellowship Association, a postdoc newsletter, a website dedicated to information for postdoctoral fellows, scientifc editing, an academic program office, and other non-academic support including institution sponsored social activities. The Academic Program office offers programs to assist faculty to enhance their own mentoring skills, and a program to encourage quarterly or biannual evaluations of fellows by advisors and advisors by fellows. SJCRH encourages all facutly members to provide mentorship to trainees. The Directors of the Projects and the Cores have a wealth of knowledge and experience to guide a young investigator and they have all agreed to provide a minimum of 5% effort as a mentor if the scholar's project is in their area of expertise. The scholar will devote a minimum of 75% effort to the scholar's program.
镰状细胞学者计划提供了一种招募和培训年轻研究人员的方法

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Russell E Ware其他文献

NEUTROPENIA ASSOCIATED WITH ELEVATED TNF-α IN COMBINED IMMUNODEFICIENCY(CID). • 54
  • DOI:
    10.1203/00006450-199604001-00073
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Terry O Harville;Stuart S Winter;Gregory A Hanissian;James E Gern;Russell E Ware
  • 通讯作者:
    Russell E Ware
A Population Pharmacokinetic Analysis of l-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects
镰状细胞病患者 L-谷氨酰胺暴露的群体药代动力学分析:剂量和食物影响的评估
  • DOI:
    10.1007/s40262-024-01349-4
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Alina Sadaf;M. Dong;A. Pfeiffer;Teresa S. Latham;T. Kalfa;A. Vinks;Russell E Ware;Charles T Quinn
  • 通讯作者:
    Charles T Quinn
CLINICAL SIGNIFICANCE OF THE ANTINUCLEAR ANTIBODY (ANA) TEST IN CHILDHOOD IMMUNE THROMBOCYTOPENIC PURPURA (ITP). • 972
  • DOI:
    10.1203/00006450-199604001-00994
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Sherri A Zimmerman;Russell E Ware
  • 通讯作者:
    Russell E Ware
Malaria prophylaxis in sickle cell anaemia: some answers, more questions
镰状细胞贫血中的疟疾预防:一些答案,更多问题
  • DOI:
    10.1016/s1473-3099(24)00745-x
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    31.000
  • 作者:
    Thomas N Williams;Russell E Ware
  • 通讯作者:
    Russell E Ware
CLONAL EXPANSION OF Vβ8+ T LYMPHOCYTES IN CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA. • 892
  • DOI:
    10.1203/00006450-199604001-00914
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Denise M Adams;Thad A Howard;Russell E Ware
  • 通讯作者:
    Russell E Ware

Russell E Ware的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Russell E Ware', 18)}}的其他基金

Enrichment
丰富
  • 批准号:
    10673664
  • 财政年份:
    2021
  • 资助金额:
    $ 30.43万
  • 项目类别:
Enrichment
丰富
  • 批准号:
    10201890
  • 财政年份:
    2021
  • 资助金额:
    $ 30.43万
  • 项目类别:
Enrichment
丰富
  • 批准号:
    10458595
  • 财政年份:
    2021
  • 资助金额:
    $ 30.43万
  • 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
  • 批准号:
    10001581
  • 财政年份:
    2017
  • 资助金额:
    $ 30.43万
  • 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
  • 批准号:
    9764461
  • 财政年份:
    2017
  • 资助金额:
    $ 30.43万
  • 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
  • 批准号:
    10223406
  • 财政年份:
    2017
  • 资助金额:
    $ 30.43万
  • 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
  • 批准号:
    10444370
  • 财政年份:
    2017
  • 资助金额:
    $ 30.43万
  • 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
  • 批准号:
    10679001
  • 财政年份:
    2017
  • 资助金额:
    $ 30.43万
  • 项目类别:
TCD With Transfusions Changing to Hydroxyurea
TCD 输血改为羟基脲
  • 批准号:
    7920182
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:
TCD With Transfusions Changing to Hydroxyurea
TCD 输血改为羟基脲
  • 批准号:
    8520382
  • 财政年份:
    2009
  • 资助金额:
    $ 30.43万
  • 项目类别:

相似海外基金

NSF Engines Development Award: Utilizing space research, development and manufacturing to improve the human condition (OH)
NSF 发动机发展奖:利用太空研究、开发和制造来改善人类状况(OH)
  • 批准号:
    2314750
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Cooperative Agreement
NSF Engines Development Award: Building an sustainable plastics innovation ecosystem in the Midwest (MN, IL)
NSF 引擎发展奖:在中西部(明尼苏达州、伊利诺伊州)建立可持续塑料创新生态系统
  • 批准号:
    2315247
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Cooperative Agreement
NSF Engines Development Award: Creating climate-resilient opportunities for plant systems (NC)
NSF 发动机开发奖:为工厂系统创造气候适应机会 (NC)
  • 批准号:
    2315399
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Cooperative Agreement
International Partnering Award: Using AI to assess senescence and mitochondrial morphology in calcifying VSMCs
国际合作奖:利用人工智能评估钙化 VSMC 的衰老和线粒体形态
  • 批准号:
    BB/Y513982/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
  • 批准号:
    EP/Z531480/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
  • 批准号:
    EP/Z531509/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
  • 批准号:
    EP/Z53156X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
  • 批准号:
    EP/Z531625/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
  • 批准号:
    EP/Z531728/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
  • 批准号:
    EP/Z531844/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了